Metin Kurtoglu, M.D., Ph.D.
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Metin Kurtoglu, M.D., Ph.D.
Metin Kurtoglu, M.D., Ph.D. is recorded as COO at Cartesian Therapeutics, Inc. (RNAC). Cartesian Therapeutics, Inc. reported in an 8-K filed April 1, 2024 that Metin Kurtoglu, M.D., Ph.D. was appointed Chief Operating Officer, effective November 13, 2023.
“Also on November 13, 2023, the Company appointed Metin Kurtoglu, M.D., Ph.D., age 45, to serve as the Company's Chief Operating Officer.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2023-11-13–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Cartesian Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Carsten Brunn CEO, Board Member
- Carsten Brunn, Ph.D. Chairman
- Blaine Davis CFO, Chief Accounting Officer
- Kevin Tan CFO
- Metin Kurtoglu COO
- June Seymour Chief Accounting Officer
- Adrian Bot Board Member
- Adrian Bot, M.D., Ph.D. Board Member
- Carrie S. Cox Board Member
- Kemal Malik Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.